Foundation Medicine’s Post

Disparities in Lung Cancer: A Discussion

Disparities in Lung Cancer: A Discussion

www.linkedin.com

Upal Basu Roy, PhD, MPH

Executive Director of Research at LUNGevity Foundation

12mo

Great to see everyone!

Thank you so much for attending today’s discussion. The views contained in this panel discussion are provided by the panelists in their individual capacity and are not meant to serve as medical advice. The opinions expressed in this panel discussion are the panelists' own and do not reflect the views of Foundation Medicine, Inc. or the panelists’ employers. There will be a dedicated Q&A session at the end of the panel. Use this comment section here to submit any questions you may have throughout the conversation. We will do our best to answer questions that are posted.

Thomas Asfeldt

Healthcare Executive | Business Acumen & Strategy | Team Building | Operational Efficiency | Communication | Mission-driven leader who guides teams with joy, stabilizes struggling companies, and delivers value.

12mo

Thank you for sharing your insights. Question for Dr. Gray in follow-up to your initial comments about distrust with the medical community, and specifically referencing Tuskegee. Is there any evidence that the distrust is waning now that we are 50 years post that awful experiment? Is trust among the medical community better when the MD is race matched with the patient (I am assuming so)? Thank you for allowing me to ask these questions.

Like
Reply
Henry J. Henderson III, Ph.D.

Oncology Medical Science Liaison| Cancer Awareness Advocate | Scientist | Speaker

12mo

Very insightful conversation! Huge thanks to all of the panelists for shedding light on a topic that can be immensely confusing.

Lynette Poyser

Medical Science Liaison

12mo

In my previous clinical practice in New Orleans our African American patients and their families were very untrusting of the health care system, I would often spend more time focusing on building a relationship of trust more than actually presenting scientific information. Sharing personal information, getting to know their personal and family dynamics was just as important!

Jessica Di Stefano, MSN, APN

Health Equity Therapeutic Area Manager at Genentech

12mo

Will this be available on-demand following today's live session?

I would be interested in knowing if LDN* is discussed in relation to lung** cancers. * https://pubmed.ncbi.nlm.nih.gov/33337537/ ** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126779/

Sydney Barned M.D.

Internal Medicine Physician | Lung Cancer Advocate | Survivor | #Justpersevere

12mo

Hello everyone! Thanks for being here.

Takara A. Scott, PhD

Director, Lead, Medical Science Liaison at Foundation Medicine

12mo

Hello Everyone :) Thanks for joining us!

Vinita K.

Senior Oncology Specialist

12mo

Good afternoon from New York

See more comments

To view or add a comment, sign in

Explore topics